Advancing Cardiac Ablation

We are committed to advancing atrial fibrillation treatment.

Advancing Cardiac Ablation

We are committed to advancing atrial fibrillation treatment.

Developing Quality Atrial Fibrillation Treatment Solutions

Developing Quality Atrial Fibrillation Treatment Solutions

AblaCor Medical Corporation’s mission is to develop innovative products to significantly advance atrial fibrillation (AFib or AF) treatment. Our company’s goal is to provide patients with long-term freedom from AFib without multiple ablation procedures.

Our first product is the AF Catheter Ablation System. It is uniquely designed to deliver pulmonary vein isolation (PVI) in a “single-shot" circumferential ablation compared to the currently marketed “point-by-point” and “balloon” technologies. Our system also allows for continuous tissue contact for precise lesion formation during the first instance.

Continuous tissue contact for precise lesion formation the first time

Features

Stabilizing Anchor

Adaptable Electrodes

Controlled Energy Delivery

Advantages

Safe, Effective Procedures

Shorter Procedures

Simpler Procedures

Benefits

Fewer Repeat Procedures

Improved Patient Outcomes

Reduced Healthcare Costs

The AblaCor Medical Corporation AF Catheter Ablation System is not approved for human use.